<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="127576">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01679275</url>
  </required_header>
  <id_info>
    <org_study_id>S54683</org_study_id>
    <nct_id>NCT01679275</nct_id>
  </id_info>
  <brief_title>Pre-operative Cerebral Oxygenation in Neonates With Congenital Heart Disease</brief_title>
  <acronym>CHD-NIRS</acronym>
  <official_title>Longitudinal Pre-operative Measurements of Cerebral Oxygenation Using Near Infrared Spectroscopy in Neonates With Congenital Heart Disease.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <authority>Belgium: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Congenital heart disease with need for early surgery in newborns is associated with an
      increased incidence in global impairment in development. The causes of these late adverse
      neurologic outcomes are multifactoral and include both fixed (or patient-specific factors)
      and modifiable factors. They relate to both the mechanism of CNS injury associated with
      congenital heart disease and its treatment. Measuring cerebral oxygenation is a promising
      non-invasive way of cerebral monitoring in a neonatal intensive care unit. The importance of
      cerebral monitoring in neonates with congenital heart problems at risk of developing
      neurological complications is increasingly recognized. In this way the most vulnerable
      moments for the newborn brain can be detected and ,if possible, lead to change in (timing
      of) treatment.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Neurodevelopmental follow up at 24 months</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Neurodevelopmental assessment at 24 months using Bayley scales of infant development II (MDI, PDI, behaviour rating, CBCL behavioural checklist and Sensory Profile.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Heart Defects, Congenital</condition>
  <arm_group>
    <arm_group_label>measuring cerebral oxygenation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>NIRS: Measurement of cerebral oxygenation using Near Infrared Spectroscopy (NIRS) during the pre-operative phase in neonates with congenital heart disease.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>measuring cerebral oxygenation</intervention_name>
    <arm_group_label>measuring cerebral oxygenation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  neonates with admission on neonatal intensive care unit with congenital heart
             disease.

        Exclusion Criteria:

          -  No informed consent.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Month</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liesbeth Thewissen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UZ Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Liesbeth Thewissen, MD</last_name>
    <phone>+3216342569</phone>
    <email>liesbeth.thewissen@uzleuven.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Neonatal Intensive Care Unit UZLeuven</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Liesbeth Thewissen, MD</last_name>
      <phone>+3216342569</phone>
      <email>Liesbeth.thewissen@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Liesbeth Thewissen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <lastchanged_date>September 5, 2012</lastchanged_date>
  <firstreceived_date>August 31, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart Defects, congenital</keyword>
  <keyword>Patient Monitoring</keyword>
  <keyword>Infant, Newborn</keyword>
  <keyword>Physiology</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Congenital Abnormalities</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
